Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 9/20 | 0.59 |
| ▸ | LPL | P06858 | 8/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.37 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30009616 | 0.99 | LIPG (0.61) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL19106674 | 0.99 | LIPG (0.61) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL27255082 | 0.93 | LIPG (0.66) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL19106680 | 0.92 | LIPG (0.60) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL18419166 | 0.92 | LIPG (0.62) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL25818405 | 0.91 | LIPG (0.62) | LIPGLPLCYP1A2IRAK4ALDH1A1 | |
| SCHEMBL19106676 | 0.91 | LIPG (0.62) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL15600476 | 0.89 | LIPG (0.71) | LIPGLPLCYP1A2ERBB2FYN | |
| SCHEMBL27254653 | 0.89 | LIPG (0.75) | LIPGLPLIRAK4ESR1ESR2 | |
| SCHEMBL27254829 | 0.88 | LIPG (0.59) | LIPGLPLCYP1A2IRAK4HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10734588-B2 | Compound for organic electronic element, and organic electronic element and electronic device using same | DUK SAN NEOLUX CO., LTD (KR) | 2020-08-04 | — | — | US | disclosed |
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20130256647-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | CANON KABUSHIKI KAISHA (JP) | 2013-10-03 | — | — | US | disclosed |
| US-20130256647-A1 | NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME | CANON KABUSHIKI KAISHA (JP) | 2013-10-03 | — | — | US | disclosed |
| US-20130175519-A1 | NEW CONDENSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-07-11 | — | — | US | disclosed |
| US-20130175519-A1 | NEW CONDENSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-07-11 | — | — | US | disclosed |
| WO-2012035962-A1 | NEW CONDENSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | NFE2L2, ESR1, VDAC2 | LIPG 2111/4885LPL 2245/4885CYP1A2 1060/4885 |
| US-10734588-B2 | Compound for organic electronic element, and organic electronic element and electronic device using same | NFE2L2, ESR1, VDAC2 | LIPG 2111/4885LPL 2245/4885CYP1A2 1060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.